The role of apoptosis in myelodysplastic syndromes

Haematologica

Volumn 87, Issue 4, 2002, Pages 337-339

  Invernizzi, Rosangela ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CYTOPENIA; EDITORIAL; HEMATOPOIESIS; HUMAN; MYELODYSPLASTIC SYNDROME;

APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; HEMATOPOIETIC STEM CELLS; HUMANS; MYELODYSPLASTIC SYNDROMES;

EID: 0036218045     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (23)

1. Programmed cell death regulation: Basic mechanisms and therapeutic opportunities
2. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis
3. Incidence and role of apoptosis in myelodysplastic syndrome: Morphological and ultrastructural assessment
4. Pathogenesis, etiology and epidemiology of myelodysplastic syndromes
5. The role of apoptosis in the pathogenesis, prognosis and therapy of hematologic malignancies
6. Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes
7. "Low-risk" myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2-related proteins
8. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes
9. Myelodysplastic syndromes: Recent advances
10. Dynamic cell cycle kinetics in vitro and in vivo in myelodysplastic syndromes with special reference to the influence of hematopoietic growth factors
11. Apoptosis and its role in the myelodysplastic syndromes: Implications for disease natural history and treatment
12. Apoptosis its significance in MDS: Controversies revisited
13. A hypothesis for the pathogenesis of myelodysplastic syndromes: Implications for new therapies
14. Cytokines, molecular biological abnormalities, and acute myelogenous leukemia
15. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells
16. Bcl-2 expression by myeloid precursors in myelodysplastic syndromes: Relation to disease progression
17. RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: A 10-year follow-up
18. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS
19. Expression of p53, bcl-2 and ras oncoproteins and apoptosis levels in acute leukaemias and myelodysplastic syndromes
20. + myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumor necrosis factor-alpha concentration
21. "TUNEL" evidence of reduced bone marrow cells apoptosis in a refractory anaemia patient treated with amifostine
22. Measurement of serum cytokine levels in patients with myelodysplastic syndromes
23. What does apoptosis have to do with clinical features in myelodysplastic syndrome?